| Molecule | Cat. No. | Product Name | 種 | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| Dkk-1 | Human Dkk-1 Protein, His Tag, premium grade | Human | HEK293 | ![]() | MALSSDS-PAGE | $130.00 20ug | ||
| Dkk-1 | Human Dkk-1 Protein, Fc Tag (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $315.00 100ug | ||
| Dkk-1 | Avitag DK1-H82F5 | Biotinylated Human Dkk-1 Protein, Fc,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug | |
| Dkk-1 | Mouse Dkk-1 Protein, His Tag | Mouse | HEK293 | ![]() | SDS-PAGE | $290.00 50ug |
| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| JS-015 | JS-015 | Phase 2 Clinical | Shanghai Junshi Biological Engineering Co Ltd | Colorectal Neoplasms; Neoplasms; Solid tumours | 詳細 |
| AGA-2115 | AGA2115; AGA-2115 | Phase 2 Clinical | Angitia Biopharmaceuticals (Guangzhou) Ltd | Osteogenesis Imperfecta | 詳細 |
| AGA-2118 | AGA-2118 | Phase 2 Clinical | Angitia Biomedicines Ltd | Osteoporosis; Osteoporosis, Postmenopausal | 詳細 |
| Sirexatamab | DKN-01; LY-2812176 | Phase 2 Clinical | Eli Lilly And Company | Bile Duct Neoplasms; Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Carcinosarcoma; Cholangiocarcinoma; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Gallbladder Neoplasms; Liver Neoplasms; Multiple Myeloma; Ovarian Neoplasms; Prostatic Neoplasms; Solid tumours; Stomach Neoplasms; Uterine Neoplasms | 詳細 |